Further studies such as recombinant LCN2 protein treatment, forced expression, or knockdown of LCN2 gene expression in glioma cells revealed that LCN2 downregulation played a key role in the BCNU resistance of glioma cells. This evidence concerns the gene LCN2 and glioma.